105.03
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
LNTH Q1 2026 Earnings: EPS Surprises to the Upside on Solid Operational ExecutionSurprise Factor Analysis - newsline.com
Healthcare Stocks to Avoid: Lantheus, Merit Medical, Addus HomeCare AnalysisNews and Statistics - IndexBox
Lantheus Holdings stock hits 52-week high at 104.05 USD By Investing.com - Investing.com Nigeria
How SNMMI’s ‘Image of the Year’ Win For LNTH-2513 At Lantheus (LNTH) Has Changed Its Investment Story - Sahm
Lantheus Holdings stock hits 52-week high at 104.05 USD - Investing.com
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight - GlobeNewswire Inc.
Lantheus Holdings Inc stock (US5156731020): Expansion push and TruVu launch keep radiopharma story i - AD HOC NEWS
Lantheus Holdings gains after report it's evaluating a sale after offer - MSN
LNTH: TruVu launches regionally in late 2024, expanding PYLARIFY access and driving market growth - TradingView
Lantheus Holdings Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Lantheus Holdings, Inc. (LNTH): Analyst Consensus Highlights a Strong Buy with a 4.21% Upside Potential - DirectorsTalk Interviews
Cash from financing activities of Lantheus Holdings Inc – XETR:0L8 - TradingView
0L8 Stock Price and Chart — XETR:0L8 - TradingView
Lantheus Holdings Inc Statistics – XETR:0L8 - TradingView
ETFs Investing in Lantheus Holdings Inc Stocks - TradingView
Why Is LNTH Stock Up After Hours? - Stocktwits
Assessing Lantheus Holdings (LNTH) Valuation After Strong Multi Month Share Price Gains - Yahoo Finance
Understanding Momentum Shifts in (LNTH) - Stock Traders Daily
Lantheus in the spotlight: Can pipeline offset pricing headwinds? By Investing.com - Investing.com Nigeria
William Blair Upgrades Lantheus(LNTH.US) to Buy Rating - Moomoo
Is Lantheus Holdings Inc (LNTH) Overvalued After 4.1% Rally? GF - GuruFocus
Lantheus (LNTH) director uses 381 shares for tax-withholding, retains over 27,000 - Stock Titan
Lantheus (LNTH) CEO Heino reports 1,227-share tax withholding and updated holdings - Stock Titan
Lantheus Holdings Jumps 5.0% Amid Sector-Wide Rally - AlphaStreet
LNTH: Isotope-driven innovation and robust supply chains fuel PET imaging growth and new product launches - TradingView
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year - The Manila Times
Lantheus Holdings, Inc. (LNTH) Investor Outlook: High Buy Ratings and Promising Growth Prospects - DirectorsTalk Interviews
LNTH Q1 2026 Earnings: EPS Surges Past Estimates, But Stock DeclinesRevenue Warning Signal - newsline.com
Lantheus Holdings (LNTH) price target increased by 10.39% to 103.33 - MSN
Lantheus Q1 2026 Earnings: EPS Beat of 15.85% Amid Flat Revenue DisclosureEPS Revision Trend - newsline.com
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
LNTH Maintains by Mizuho -- Price Target Raised to $115 - GuruFocus
Mizuho raises Lantheus stock price target to $115 amid sale talks - Investing.com UK
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating, Raises Target Price to $115 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: IQVIA Holdings (IQV), Lantheus (LNTH) - The Globe and Mail
Lantheus to present at William Blair Growth Stock Conference on June 3, highlighting its radiopharmaceutical advances. - Pluang
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference - The Manila Times
Watch Lantheus' June 3 William Blair fireside chat online - Stock Titan
Mizuho raises Lantheus stock price target to $115 amid sale talks By Investing.com - Investing.com South Africa
Lantheus explores $7B sale: report - The Business Journals
Truist Financial Maintains Lantheus(LNTH.US) With Buy Rating - Moomoo
Lantheus Holdings (LNTH) Surges 9%: Key Levels and Momentum DriversHigh Dividend Factor - The Legal Advocate
Avoiding Lag: Real-Time Signals in (LNTH) Movement - Stock Traders Daily
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse With a 23.48% Return on Equity - DirectorsTalk Interviews
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):